Arbutus Biopharma

$3.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.46 (-12.71%) As of 7:41 PM UTC today

Why Robinhood?

You can buy or sell ABUS and other stocks, options, and ETFs commission-free!

About ABUS

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA. The listed name for ABUS is Arbutus Biopharma Corporation Common Stock.

CEO

William H. Collier

Employees

Headquarters

Warminster, Pennsylvania

Founded

2005

Market Cap

258.97M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.72M

High Today

$3.60

Low Today

$3.01

Open Price

$3.60

Volume

3.83M

52 Week High

$9.02

52 Week Low

$0.88

ABUS News

Benzinga7h

Recap: Arbutus Biopharma Q4 Earnings

Shares of Arbutus Biopharma (NASDAQ:ABUS) fell 6.0% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 50.

BenzingaMar 3

Earnings Preview: Arbutus Biopharma

On Thursday, March 04, Arbutus Biopharma (NASDAQ:ABUS) will release its latest earnings report. Check out Benzinga's preview to understand the implications. Ne

Analyst Ratings

71%

of 7 ratings

Buy

71%

Hold

29%

Sell

ABUS Earnings

-$0.73

-$0.49

-$0.24

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

-$0.22 per share

Actual

-$0.23 per share

Replay Earnings Call